CLINICAL RESEARCH: ATHEROSCLEROSIS
CD40 Ligand+ Microparticles From Human Atherosclerotic Plaques Stimulate Endothelial Proliferation and AngiogenesisA Potential Mechanism for Intraplaque Neovascularization
Aurélie S. Leroyer, PhD*, ,
Pierre-Emmanuel Rautou, MD*, ,
Jean-Sébastien Silvestre, PhD*, ,
Yves Castier, MD, PhD ,
Guy Lesèche, MD, PhD ,
Cécile Devue, BSc*, ,
Micheline Duriez, BSc*, ,
Ralf P. Brandes, MD, PhD ,
Esther Lutgens, MD, PhD||,
Alain Tedgui, PhD*, and
Chantal M. Boulanger, PhD*, ,*
* Institut National de la Santé et de la Recherche Médicale, Cardiovascular Research Center INSERM Lariboisière, Paris
Paris VII University, Paris
Assistance Publique Hopitaux de Paris, AP-HP Hopital Bichat, Vascular Surgery Department, Paris, France
Institut fur Kardiovasculare Physiologie, Johann Wolfgang Goethe-Universitat, Frankfurt-am-Main, Germany
|| Department of Pathology, Cardiovascular Research Institute Maastricht (CARIM), University of Maastricht, Maastricht, the Netherlands
Manuscript received May 5, 2008;
revised manuscript received July 3, 2008,
accepted July 28, 2008.
* Reprint requests and correspondence: Dr. Chantal M. Boulanger, INSERM CRC Lariboisière, Unité 689, 41 bd Chapelle, 75475 Paris, France (Email: chantal.boulanger{at}inserm.fr).
Objectives: Our goal was to demonstrate that microparticles (MPs) are the endogenous signal leading to neovessel formation through CD40 ligation in human atherosclerotic plaques.
Background: Vulnerable atherosclerotic plaques prone to rupture are characterized by an increased number of vasa vasorum and frequent intraplaque hemorrhage. Although inflammatory cytokines, growth factors, or CD40/CD40 ligand (CD40L) are possible candidates, the mechanism of atherosclerotic plaque neovascularization remains unknown. Atherosclerotic plaques contain large amounts of membrane-shed submicron MPs released after cell activation or apoptosis.
Methods: Microparticles were isolated from endarterectomy specimens surgically obtained from 26 patients and characterized by phosphatidylserine exposure and specific markers of cellular origin.
Results: Plaque MPs increased both endothelial proliferation assessed by 3H-thymidine incorporation and cell number and stimulated in vivo angiogenesis in Matrigel (BD Biosciences, San Diego, California) assays performed in wild-type and BalbC/Nude mice, whereas circulating MPs had no effect. Microparticles from symptomatic patients expressed more CD40L and were more potent in inducing endothelial proliferation, when compared with asymptomatic plaque MPs. Most of CD40L+ MPs (93%) isolated from human plaques were of macrophage origin. Microparticle-induced endothelial proliferation was impaired by CD40L or CD40-neutralizing antibodies and abolished after endothelial CD40-ribonucleic acid silencing. In addition, the proangiogenic effect of plaque MPs was abolished in Matrigel assays performed in the presence of CD40L-neutralizing antibodies or in CD40-deficient mice.
Conclusions: These results demonstrate that MPs isolated from human atherosclerotic lesions express CD40L, stimulate endothelial cell proliferation after CD40 ligation, and promote in vivo angiogenesis. Therefore, MPs could represent a major determinant of intraplaque neovascularization and plaque vulnerability.
Key Words: atherosclerosis microparticles inflammation angiogenesis proliferation VEGF
|
Abbreviations and Acronyms
| | AnnV = Annexin V | | CD40L = CD40 ligand | | COX = cyclooxygenase | | DMEM = Dulbecco's modified eagle medium | | ELISA = enzyme-linked immunoadsorbent assay | | FCS = fetal calf serum | | FITC = fluoroisothiocyanate | | HUVEC = human umbilical vein endothelial cell | | IL = interleukin | | MP = microparticle | | PC5 = phycoerythrin-cyanin 5 | | PE = phycoerythrin | | siRNA = small interfering ribonucleic acid | | VEGF = vascular endothelial growth factor |
|
Related Articles
-
Microparticles, Debris That Hurts
- Gerard Pasterkamp and Dominique de Kleijn
J. Am. Coll. Cardiol. 2008 52: 1312-1313.
[Full Text]
[PDF]
-
Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 52: A31.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
A. Angelillo-Scherrer
Leukocyte-Derived Microparticles in Vascular Homeostasis
Circ. Res.,
January 20, 2012;
110(2):
356 - 369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Berda-Haddad, S. Robert, P. Salers, L. Zekraoui, C. Farnarier, C. A. Dinarello, F. Dignat-George, and G. Kaplanski
Sterile inflammation of endothelial cell-derived apoptotic bodies is mediated by interleukin-1{alpha}
PNAS,
December 20, 2011;
108(51):
20684 - 20689.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. K. Singh, V. Kundumani-Sridharan, and G. N. Rao
12/15-Lipoxygenase gene knockout severely impairs ischemia-induced angiogenesis due to lack of Rac1 farnesylation
Blood,
November 17, 2011;
118(20):
5701 - 5712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-E. Rautou, A.-C. Vion, N. Amabile, G. Chironi, A. Simon, A. Tedgui, and C. M. Boulanger
Microparticles, Vascular Function, and Atherothrombosis
Circ. Res.,
August 19, 2011;
109(5):
593 - 606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Cheng, D. Tempel, W. K. Den Dekker, R. Haasdijk, I. Chrifi, F. L. Bos, K. Wagtmans, E. H. van de Kamp, L. Blonden, E. A. L. Biessen, et al.
Ets2 Determines the Inflammatory State of Endothelial Cells in Advanced Atherosclerotic Lesions
Circ. Res.,
August 5, 2011;
109(4):
382 - 395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Martinez and R. Andriantsitohaina
Microparticles in Angiogenesis: Therapeutic Potential
Circ. Res.,
June 24, 2011;
109(1):
110 - 119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Gyorgy, K. Modos, E. Pallinger, K. Paloczi, M. Pasztoi, P. Misjak, M. A. Deli, A. Sipos, A. Szalai, I. Voszka, et al.
Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters
Blood,
January 27, 2011;
117(4):
e39 - e48.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Tushuizen, M. Diamant, A. Sturk, and R. Nieuwland
Cell-Derived Microparticles in the Pathogenesis of Cardiovascular Disease: Friend or Foe?
Arterioscler Thromb Vasc Biol,
January 1, 2011;
31(1):
4 - 9.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Shai and D. Varon
Development, Cell Differentiation, Angiogenesis--Microparticles and Their Roles in Angiogenesis
Arterioscler Thromb Vasc Biol,
January 1, 2011;
31(1):
10 - 14.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Dignat-George and C. M. Boulanger
The Many Faces of Endothelial Microparticles
Arterioscler Thromb Vasc Biol,
January 1, 2011;
31(1):
27 - 33.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Moura and M. Tjwa
Platelets suppress Treg recruitment
Blood,
November 18, 2010;
116(20):
4035 - 4037.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. F. Mause and C. Weber
Microparticles: Protagonists of a Novel Communication Network for Intercellular Information Exchange
Circ. Res.,
October 29, 2010;
107(9):
1047 - 1057.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. RODRIGUEZ-RODRIGUEZ, S. CASTANEDA, T. R. VAZQUEZ-RODRIGUEZ, I. C. MORADO, B. MARI-ALFONSO, C. GOMEZ-VAQUERO, J. A. MIRANDA-FILLOY, J. NARVAEZ, N. ORTEGO-CENTENO, R. BLANCO, et al.
Influence of CD40 rs1883832 Polymorphism in Susceptibility to and Clinical Manifestations of Biopsy-proven Giant Cell Arteritis
J Rheumatol,
October 1, 2010;
37(10):
2076 - 2080.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chahed, A. S. Leroyer, M. Benzerroug, D. Gaucher, A. Georgescu, S. Picaud, J.-S. Silvestre, A. Gaudric, A. Tedgui, P. Massin, et al.
Increased Vitreous Shedding of Microparticles in Proliferative Diabetic Retinopathy Stimulates Endothelial Proliferation
Diabetes,
March 1, 2010;
59(3):
694 - 701.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Le Dall, B. Ho-Tin-Noe, L. Louedec, O. Meilhac, C. Roncal, P. Carmeliet, S. Germain, J.-B. Michel, and X. Houard
Immaturity of microvessels in haemorrhagic plaques is associated with proteolytic degradation of angiogenic factors
Cardiovasc Res,
January 1, 2010;
85(1):
184 - 193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Antoniades, C. Bakogiannis, D. Tousoulis, A. S. Antonopoulos, and C. Stefanadis
The CD40/CD40 Ligand System: Linking Inflammation With Atherothrombosis
J. Am. Coll. Cardiol.,
August 18, 2009;
54(8):
669 - 677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Crea and F. Andreotti
The unstable plaque: a broken balance
Eur. Heart J.,
August 1, 2009;
30(15):
1821 - 1823.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mayr, D. Grainger, U. Mayr, A. S. Leroyer, G. Leseche, A. Sidibe, O. Herbin, X. Yin, A. Gomes, B. Madhu, et al.
Proteomics, Metabolomics, and Immunomics on Microparticles Derived From Human Atherosclerotic Plaques
Circ Cardiovasc Genet,
August 1, 2009;
2(4):
379 - 388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sanz, P. R. Moreno, and V. Fuster
The Year in Atherothrombosis
J. Am. Coll. Cardiol.,
April 14, 2009;
53(15):
1326 - 1337.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Morel, F. Toti, N. Morel, and J.-M. Freyssinet
Microparticles in endothelial cell and vascular homeostasis: are they really noxious?
Haematologica,
March 1, 2009;
94(3):
313 - 317.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Pasterkamp and D. de Kleijn
Microparticles, Debris That Hurts
J. Am. Coll. Cardiol.,
October 14, 2008;
52(16):
1312 - 1313.
[Full Text]
[PDF]
|
 |
|
|